Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Recs

0
Player Avatar OklaBoston (67.72) Submitted: 11/20/2012 6:51:54 PM : Outperform Start Price: $34.20 CLSN Score: -0.38

This stock should make it into the black in a few more quarters. Much insider buying and ZERO selling in the past year.

Featured Broker Partners


Advertisement